Allarity Therapeutics reports Q2 2026 results; Stenoparib Phase 3-ready campaign completed
Allarity Therapeutics reports second quarter 2026 results and states it has completed the Phase 3-ready Stenoparib manufacturing campaign.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.